Thrombocytopenia Clinical Trials in Changsha, Hunan
4 recruitingChangsha, Hunan, China
Showing 1–4 of 4 trials
Recruiting
Not Applicable
Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital18 enrolled1 locationNCT06973356
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 2Phase 3
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital142 enrolled14 locationsNCT06202625
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856